A Minimal Physiologically‐Based Pharmacokinetic Model for Tacrolimus in Living‐Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype
In adult patients after living‐donor liver transplantation, postoperative days and the cytochrome P450 3A5 (CYP3A5) genotype are known to affect tacrolimus pharmacokinetics. In this study, we constructed a physiologically‐based pharmacokinetic model adapted to the clinical data and evaluated the con...
Main Authors: | Kotaro Itohara, Ikuko Yano, Tetsunori Tsuzuki, Miwa Uesugi, Shunsaku Nakagawa, Atsushi Yonezawa, Hideaki Okajima, Toshimi Kaido, Shinji Uemoto, Kazuo Matsubara |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12420 |
Similar Items
-
Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients.
by: Ayami Tsuchimoto, et al.
Published: (2014-01-01) -
Nutritional Therapy in Liver Transplantation
by: Ahmed Hammad, et al.
Published: (2017-10-01) -
Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
by: Jefferson Antonio Buendía, et al.
Published: (2020-09-01) -
Proposal for new selection criteria considering pre‐transplant muscularity and visceral adiposity in living donor liver transplantation
by: Yuhei Hamaguchi, et al.
Published: (2018-04-01) -
Effect of <i>CYP3A5</i> on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients
by: Jong Man Kim, et al.
Published: (2020-09-01)